KS02.5.A COVID19 impact on the neuro-oncological population. evaluation of critical issues and resources of patients and caregivers

por Anghileri, E, Tramacere, I, Morlino, S, Leuzzi, C, Pareja Gutierrez, L, Fariselli, L, Silvani, A, Berrini, F
Publicado 2022

P12. Combination of radiotherapy and chemotherapy with dendritic cell immunotherapy in glioblastoma patients induces NK and NKT cell responses

por Pellegatta, S, Eoli, M, Bruzzone, MG, Cuzzubbo, S, Anghileri, E, Antozzi, C, Frigerio, S, Pollo, B, Parati, EA, Finocchiaro, G
Publicado 2014

P1359: USING GENE-MODIFIED AUTOLOGOUS STEM CELLS PROGENY TO REEDUCATE THE TUMOR IMMUNE MICROENVIRONMENT OF SOLID TUMORS (TEM-GBM STUDY)

por Farina, F., Gentner, B., Eoli, M., Finocchiaro, G., Capotondo, A., Cuccarini, V., Naldini, M. M., Barcella, M., Anghileri, E., Brambilla, V., Bruzzone, M. G., Carrabba, M., D’Alessandris, G., Di Meco, F., Ferla, V., Franzin, A., Ferroli, P., Gagliardi, F., Legnani, F., Mazzoleni, S., Mortini, P., Olivi, A., Pallini, R., Patanè, M., Paterra, R., Pollo, B., Saini, M., Snider, S., Naldini, L., Russo, C., Ciceri, F.
Publicado 2022